- Joined
- Feb 26, 2003
- Messages
- 8,860
- Reaction score
- 3,420
Don't think the CEO is the only one who deserves the attention of the Epipen price hike.
Former USC Pharmacy Dean (Randall L. Vanderveen, PhD, R.Ph.) is on the Mylan Board and the Board gave her the go ahead. That is right...a pharmacist.
Op-Ed: The real EpiPen scandal we should be talking about: http://www.cnbc.com/id/103893464
Sent from my iPhone using SDN mobile app
Former USC Pharmacy Dean (Randall L. Vanderveen, PhD, R.Ph.) is on the Mylan Board and the Board gave her the go ahead. That is right...a pharmacist.
Op-Ed: The real EpiPen scandal we should be talking about: http://www.cnbc.com/id/103893464
Sent from my iPhone using SDN mobile app